A review of active investors in US and European life science/biotechnology companies, and current venture capital market dynamics. Click here to download presentation Life Science Venture Capital 2012 Update View more presentations from burakalpar
Read more →Raising venture capital is tough – difficult for a seasoned entrepreneur, a minefield for the novice. The time and effort required to raise venture capital is often underestimated, and can seriously disrupt a company with dozens of other business priorities. In this article I cover the VM Index process for raising venture capital. These best [...]
Read more →I regularly like to review recent venture capital financings against the VM Index venture capital database to ensure our investor search process and methodology maintains its accuracy. Today I was looking at the funding history of Netherlands-based Biotech arGEN-X who have recently announced their second round VC fund raising in which they raised €27.5 million [...]
Read more →To use a DCF you need a CF to D. For a start-up you'll only have a bunch of zeros where the revenue line should be, and the rest of your model will be completely meaningless. Start-up valuations are based on (inter alia): Exit potential and time-scale Benchmarking with other similar companies at a similar [...]
Read more →Top investors vary by location, and usually represent a tiny proportion of the entire investing population. A regional analysis of biotech investment activity (number of deals) covering the 5 years from 2007 to 2011 has identified the following top investors: West Coast US – Domain Associates (428 total active investors) North East US – Polaris [...]
Read more →Highlights from recent IT venture capital investment activity. VM Index subscribers see full details of all 60 IT Venture Capital deals from the past week plus profiles and analysis of thousands of investors and venture-backed companies. May 9th, 2012 – Brooklyn, NY Etsy Raises $40M To Fuel International Expansion Etsy, the popular online marketplace [...]
Read more →Highlights from recent Life Science venture capital news. VM Index subscribers see full details of all 13 Health Care, Life Science & Biotech Venture Capital deals from the past week plus profiles and analysis of thousands of investors and venture-backed companies. May 8th, 2012 – Cambridge, MA Eleven Biotherapeutics Secures $20 Million and Expands Series [...]
Read more →A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week. Total No. Deals NA EU Total Raised $ Total Raised € 76 60 16 723.7 548.0 North America No. Deals Total $ Total € Average $ Average € 60 567.8 429.7 11.4 [...]
Read more →Highlights from recent IT venture capital investment activity. May 02, 2012 – Chicago, IL Total Attorneys Secures $15 Million Growth Capital Investment Led by Bain Capital Ventures Total Attorneys, the legal industry’s leading customer acquisition and practice management platform, today announced the closing of a $15 million growth capital investment. The investment was led by [...]
Read more →Highlights from recent Life Science venture capital news. May 01, 2012 – San Francisco, CA Castlight Health Secures $100 Million in Series D Funding Castlight Health, the leading provider of health care transparency solutions, today announced it has secured $100 million in Series D funding. With this investment, the company will aggressively capitalize on growing [...]
Read more →A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week. Total No. Deals NA EU Total Raised $ Total Raised € 54 45 9 346.5 262.6 North America No. Deals Total $ Total € Average $ Average € 45 299.8 227.3 [...]
Read more →Highlights from recent IT venture capital investment activity. WeVideo Secures $19.2M in Funding Crest Capital Ventures Sees Compelling Advantages in Cloud-Based Collaborative Video Editing SUNNYVALE, Calif., April 24, 2012– WeVideo (www.wevideo.com), creators of the world’s most powerful and easy-to-use online video editing platform, today announced that it has secured $19.2M in a Series A funding [...]
Read more →Highlights from recent Life Science venture capital news. Aggredyne Closes $3 Million Series A Financing Company prepares to file 510(k) for clearance to market AggreGuideTM A-100 HOUSTON, April 23, 2012– Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series [...]
Read more →